Patent · US Active

Compositions for activating pyruvate kinase

US10472371B2 · kind B2 · utility

11Cited by

25References

3Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

Xiaozhang Zheng · Lexington, US
Neal Green · Newton, US
Gary Gustafson · Ridgefield, US
David R. Lancia, Jr. · Boston, US
Lorna Helen Mitchell · Auckland, NZ
Tatiana Shelekhin · Ridgefield, US

Key dates

Filing date	Jan 11, 2019
Grant date	Nov 12, 2019
Priority date	—
Expiry date	Jan 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions for the activation of PKR are provided, as well as therapeutic administration of the compositions for the treatment of pyruvate kinase-related medical conditions, such as pyruvate kinase deficiency (PKD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.